Showing results (21-30 of 262) with videos related to

Sort By:
Pageof 27
Neuroscience and Biobehavioral Reviews|February 16, 2023
Early auditory processing dysfunction in schizophrenia: Mechanisms and implicationsClément Dondé, Joshua T Kantrowitz, Alice Medalia, et al.
Neuroimage. Clinical|June 6, 2018
Sensory and cross-network contributions to response inhibition in patients with schizophreniaMatthew J Hoptman, Emily M Parker, Sangeeta Nair-Collins, et al.
Alzheimer'S Research & Therapy|March 1, 2023
Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairmentDaniel C Javitt, Antigona Martinez, Pejman Sehatpour, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 20, 2021
Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058Pejman Sehatpour, Daniel C Javitt, Heloise M De Baun, et al.
Schizophrenia Bulletin|August 28, 2020
Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in SchizophreniaElisa C Dias, Heather Sheridan, Antígona Martínez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2015
Neural Substrates of Auditory Emotion Recognition Deficits in SchizophreniaJoshua T Kantrowitz, Matthew J Hoptman, David I Leitman, et al.
Neuroimage|September 5, 2020
Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learningPejman Sehatpour, Clément Dondé, Matthew J Hoptman, et al.
Brain Stimulation|March 30, 2019
Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension studyJoshua T Kantrowitz, Pejman Sehatpour, Michael Avissar, et al.
Frontiers in Behavioral Neuroscience|March 3, 2022
Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in SchizophreniaAntígona Martínez, Russell H Tobe, Pablo A Gaspar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2020
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patientsJoshua T Kantrowitz, Daniel C Javitt, Robert Freedman, et al.
Pageof 27